Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine

Area of Science:

• Neuroscience
• Psychopharmacology
• Medical Imaging

Background:

• Psychedelic compounds like 3,4-methylenedioxymethamphetamine (MDMA) show therapeutic potential for psychiatric disorders.
• Blood-oxygenation-level-dependent (BOLD) functional MRI (fMRI) studies suggest MDMA inhibits brain activity, contrasting with earlier excitatory hypotheses.
• Interpreting psychedelic-induced hemodynamic changes is challenging due to potent vascular effects.

Purpose of the Study:

• To investigate the acute effects of MDMA using simultaneous positron emission tomography (PET)/fMRI in rats.
• To correlate hemodynamic changes (BOLD fMRI) with alterations in glucose utilization (18F-FDG fPET) and serotonin transporter (SERT) occupancy (11C-DASB PET).

Main Methods:

• Simultaneous PET/fMRI in rats to assess acute MDMA effects.
• Utilized 18F-FDG fPET/fMRI to measure glucose metabolism and BOLD signal.
• Employed 11C-DASB PET/fMRI to quantify serotonin transporter (SERT) occupancy.

Main Results:

• MDMA induced localized increases in glucose metabolism within limbic areas involved in emotional processing.
• Global cerebral and extracerebral hemodynamic decreases accompanied the increased glucose metabolism.
• A strong correlation was observed between SERT occupancy and regional BOLD signal reductions post-MDMA.

Conclusions:

• Hemodynamic decreases following acute MDMA are non-neuronal and originate peripherally.
• MDMA activates neurons in limbic areas, while serotonin increases cause neurovascular uncoupling via vascular effects.
• Recommends 18F-FDG fPET as a robust measure for psychedelic pharmacologic research, urging reassessment of prior studies relying on neurovascular coupling.